Hepatitis C Drugs Carry Potentially Deadly Side Effect

Shared by:

Expensive hepatitis C drugs that can cure patients may come with a big risk for some; they can cause a second hepatitis virus, hepatitis B, to become active again, the Food and Drug Administration (FDA)

healthscienceandtechnology.com

7 Oct 2016 - General

Medical Student

According to WHO, there are between 130–150 million people globally have chronic hepatitis C infection. A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer. Until recently, hepatitis C treatment was based on therapy with interferon and ribavirin, which required weekly injections for 48 weeks, cured approximately half of treated patients, but caused frequent and sometimes life-threatening adverse reactions.
Recently, new antiviral drugs have...

(Total 121 words)

Pharmacist

‹ › ×